Evidence for a polyclonal etiology of palmar fibromatosis

Journal of Hand Surgery

Volumn 24, Issue 2, 1999, Pages 339-344

  Chansky, Howard A ^a,b   Trumble, Thomas E ^a   Conrad III, Ernest U ^a   Wolff, John F ^a   Murray, Lorne W ^a   Raskind, Wendy H ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Department of Orthopaedics 112ORT ^*  (United States)

Author keywords

Dupuytren's; Etiology; Palmar fibromatosis; X inactivation

Indexed keywords

ANDROGEN RECEPTOR; DNA;

ADULT; ARTICLE; CASE REPORT; DUPUYTREN CONTRACTURE; ETIOLOGY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; RECEPTOR GENE; X CHROMOSOME INACTIVATION;

EID: 0033021181     PISSN: 03635023     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhsu.1999.0339     Document Type: Article

References (44)

1. An HS, Southworth SR, Jackson WT, Russ B. Cigarette smoking and Dupuytren's contracture of the hand. J Hand Surg 1988;13A:872-874.
2. Arkkila PET, Kantola IM, Viikari JSA, Rönnemaa T, Vähätalo MA. Dupuytren's disease in type 1 diabetic patients: a five-year prospective study. Clin Exp Rheumatol 1996; 14:59-65.
3. Chammas M, Bousquet P, Renard E, Poirier J-L, Jaffiol C, Allieu Y. Dupuytren's disease, carpal tunnel syndrome, trigger finger, and diabetes mellitus. J Hand Surg 1995; 20A:109-114.
4. Noble J, Heathcote JG, Cohen H. Diabetes mellitus in the aetiology of Dupuytren's disease. J Bone Joint Surg 1984; 666:322-325.
5. Noble J, Arafa M, Royle SG, McGeorge G, Crank S. The association between alcohol, hepatic pathology and Dupuytren's disease. J Hand Surg 1992;17B:71-74.
6. Stewart HD, Innes AR, Burke FD. The hand complications of Colles' fractures. J Hand Surg 1985;10B:103-106.
7. Bertoni F, Bacchini P. Palmar (Dupuytren's disease) and plantar (Ledderhose's disease) fibromatoses. In: Campanacci M, ed. Bone and soft tissue tumors. New York: Springer-Verlag Wien, 1990:1067-1069.
8. Hill NA. Dupuytren's contracture. Hand Clin 1989;5:349-357.
9. Alman BA, Greel DA, Ruby LK, Goldberg MJ, Wolfe HJ. Regulation of proliferation and platelet-derived growth factor expression in palmar fibromatosis (Dupuytren contracture) by mechanical strain. J Orthop Res 1996;14:722-728.
10. Badalamente MA, Sampson SP, Hurst LC, Dowd A, Miyasaka K. The role of transforming growth factor beta in Dupuytren's disease. J Hand Surg 1996;21A:210-215.
11. Berndt A, Kosmehl H, Mandel U, et al. TGFβ and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin. Histochem J 1995;27:1014-1020.
12. Roholl PJM, Skottner A, Prinsen I, Lips CJM, Den Otter W, Van Unnik JAM. Expression of insulin-like growth factor 1 in sarcomas. Histopathology 1990;16:455-460.
13. Zamora RL, Kraemer BA, Erlich HP, Groner JP. Presence of growth factors in palmar and plantar fibromatoses. J Hand Surg 1994;19A:435-441.
14. Muller E, Castagnaro M, Yandel DW, Wolfe HJ, Alman BA. Molecular genetic and immunohistochemical analysis of the tumor suppressor genes Rb and p53 in palmar and aggressive fibromatosis. Diagn Mol Pathol 1996;5:194-200.
15. Kosmehl H, Berndt A, Katenkamp D, et al. Differential expression of fibronectin splice variants, oncofetal glycosylated fibronectin and laminin isoforms in nodular palmar fibromatosis. Pathol Res Pract 1995;191:1105-1113.
16. Fialkow PJ. Single or multiple cell origin for tumors? N Engl J Med 1971;285:1198-1199 (editorial).
17. Nowell PC. The clonal evolution of tumor cell populations. Science 1976;194:23-28.
18. Fialkow PJ. Primordial cell pool size and lineage relationships of five human cell types. Ann Hum Genet 1973;37: 39-48.
19. Alers JC, Krijtenburg PJ, Vissers CJ, Bosman FT, van der Kwast TK, van Dekken H. Cytogenetic heterogeneity and histologic tumor growth patterns in prostatic cancer. Cytometry 1995;21:84-94.
20. Alman BA, Pajerski ME, Diaz-Cano S, Corboy K, Wolfe HJ. Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder. Diagn Mol Pathol 1997;6:98-101.
21. Bedi GC, Westra WH, Gabrielson E, Koch W, Sidransky D. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res 1996;56:2484-2487.
22. Choong PFM, Willén H, Nilbert M, et al. Pigmented villonodular synovitis: monoclonality and metastasis - a case for neoplastic origin? Acta Orthop Scand 1995;66:64-68.
23. Dodson MK, Hartmann LC, Cliby WA, et al. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas. Cancer Res 1993;53:4456-4460.
24. Enomoto T, Fujita M, Inoue M, Tanizawa O, Nomura T, Shroyer RR. Analysis of clonality by amplification of short tandem repeats: carcinomas of the female reproductive tract. Diagn Mol Pathol 1994;3:292-297.
25. Fearon ER, Hamilton SR, Vogelstein B. Clonal analysis of human colorectal tumors. Science 1987;238:193-197.
26. Gaffey MJ, Iezzoni JC, Weiss LM. Clonal analysis of focal nodular hyperplasia of the liver. Am J Pathol 1996;148: 1089-1096.
27. Green AJ, Sepp T, Yates JRW. Clonality of tuberous sclerosis harmatomas shown by non-random X-chromosome inactivation. Hum Genet 1996;97:240-243.
28. Lucas DR, Shroyer KR, McCarthy PJ, Markham NE, Fujita M, Enomoto TE. Desmoid tumor is a clonal cellular proliferation: PCR amplification of HUMARA for analysis of patterns of X-chromosome inactivation. Am J Surg Pathol 1997;21:306-311.
29. Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H. Differentiation of primary and secondary breast cancer with clonal analysis. Surgery 1994;115:458-462.
30. Paradis V, Laurent A, Flejou J-F, Vidaud M, Bedossa P. Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation. Hepatology 1997;26:891-895.
31. Quade BJ, McLachlin CM, Soto-Wright V, Zuckerman J, Mutter GL, Morton CC. Disseminated peritoneal leiomyomatosis: clonality analysis by X chromosome inactivation and cytogenetics of a clinically benign smooth muscle proliferation. Am J Pathol 1997;150:2153-2166.
32. Sakkers RJB, de Jong D, van der Heul RO. X-chromosome inactivation in patients who have pigmented villonodular synovitis. J Bone Joint Surg 1991;73A:1532-1536.
33. Vogelstein B, Fearon ER, Hamilton SR, et al. Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res 1987;47:4806-4813.
34. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 1992;51:1229-1239.
35. Adamson JW, Fialkow PJ, Murphy S, Prchal JF, Steinmann L. Polycythemia vera: stem-cell and probable clonal origin of the disease. N Engl J Med 1976;295:913-916.
36. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
37. Mullenbach R, Lagoda PJ, Welter C. An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet 1989;5:391.
38. Mashal RD, Lester SC, Sklar J. Clonal analysis by study of X chromosome inactivation in formalin-fixed paraffin-embedded tissue. Cancer Res 1993;53:4676-4679 [published erratum appears in Cancer Res 1994;54:1873].
39. Bridge JA, Sreekantaiah C, Mouron B, Neff JR, Sandberg AA, Wolman SR. Clonal chromosomal abnormalities in desmoid tumors: implications for histopathogenesis. Cancer 1992;69:430-436.
40. Fletcher JA, Pinkus GS, Weidner N, Morton CC. Lineage-restricted clonality in biphasic solid tumors. Am J Pathol 1991;138:1199-1207.
41. Jacobson RJ, Salo A, Fialkow PJ. Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood 1978;51:189-194.
42. Hasegawa T, Hirose T, Kudo E, Abe J, Hizawa K. Cytoskeletal characteristics of myofibroblasts in benign neoplastic and reactive fibroblastic lesions. Virchows Arch A Pathol Anat Histopathol 1990;416:375-382.
43. Badalamente MA, Hurst LC, Sampson SP. Prostaglandins influence myofibroblast contractility in Dupuytren's disease. J Hand Surg 1988;13A:867-871.
44. Berndt A, Kosmehl H, Katenkamp D, Tauchmann V. Appearance of the myofibroblastic phenotype in Dupuytren's disease is associated with a fibronectin, laminin, collagen type IV and tenascin extracellular matrix. Pathobiology 1994;62:55-58.